{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:02:01Z","timestamp":1784354521908,"version":"3.55.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Reactive oxygen species (ROS) play a vital role in the pathophysiology of the skin disease rosacea, a chronic, genetically-determined and UV-triggered disease, leading to facial redness and blemishes and exhibiting a deep impact on a patient's self-esteem and quality of life. ROS can cause oxidative damage to nucleic acids, sugars, proteins and lipids, thereby contributing to adverse effects on the skin. Metronidazole has been the first-line topical agent therapy for many years; nevertheless the mechanism of action is still not well understood. The therapeutic efficacy of metronidazole has been attributed to its antioxidant effects, which can involve two pathways: decreased generation of ROS within tissues or scavenging and inactivation of existing ROS. Previous investigations have shown that metronidazole reduces ROS by decreasing ROS production in cellular in-vitro systems. The aim of the following study was to demonstrate that metronidazole additionally exhibits anti-oxidative properties in a cell-free system, by acting as an antioxidant scavenger. A simple skin lipid model (oxidative) system and a complex skin adapted lipid system in conjunction with thiobarbituric acid (TBA) test, a quantitative assay for the detection of malondialdehyde (MDA) and therefore lipid peroxidation, were used to determine the antioxidative properties of metronidazole after UV irradiation. Results clearly show that metronidazole has antioxidative properties in a cell-free environment, acting as a free radical scavenger. Simple skin lipid model: in the presence of 10, 100 and 500 \u03bcg mL\u22121 metronidazole the MDA concentration was reduced by 25, 36 and 49%, respectively. Complex skin lipid system: in the presence of 100 and 500 \u03bcg mL\u22121 metronidazole the MDA concentration was reduced by 19 and 34%, respectively. The results obtained in this study and from previous publications strongly suggest that metronidazole exhibits antioxidative effects via two mechanisms: decrease in ROS production through modulation of neutrophil activity and decrease in ROS concentration by exhibiting ROS scavenging properties. The remarkable clinical efficacy of metronidazole in the treatment of rosacea is probably due to its ability to decrease ROS via different mechanisms, thereby protecting skin components from induced damage.<\/jats:p>","DOI":"10.1211\/jpp.59.8.0010","type":"journal-article","created":{"date-parts":[[2007,8,24]],"date-time":"2007-08-24T00:07:47Z","timestamp":1187914067000},"page":"1125-1130","source":"Crossref","is-referenced-by-count":46,"title":["Scavenging properties of metronidazole on free oxygen radicals in a skin lipid model system"],"prefix":"10.1093","volume":"59","author":[{"given":"Sabrina","family":"Narayanan","sequence":"first","affiliation":[{"name":"Medical Department, Galderma Laboratorium GmbH , Georg-Glock-Str. 8, 40474 D\u00fcsseldorf,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"H\u00f9nerbein","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy, Martin Luther University Halle-Wittenberg , Wolfgang-Langenbeck-str. 4, D-06120 Halle\/Saale,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melkamu","family":"Getie","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy, Martin Luther University Halle-Wittenberg , Wolfgang-Langenbeck-str. 4, D-06120 Halle\/Saale,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"J\u00e4ckel","sequence":"additional","affiliation":[{"name":"Medical Department, Galderma Laboratorium GmbH , Georg-Glock-Str. 8, 40474 D\u00fcsseldorf,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard H H","family":"Neubert","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy, Martin Luther University Halle-Wittenberg , Wolfgang-Langenbeck-str. 4, D-06120 Halle\/Saale,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,8,1]]},"reference":[{"key":"2024103109355958100_cit1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF00402621","article-title":"The inhibition of free radical generation by human neutrophils through the synergistic effects of metronidazole with palmitoleic acid: a possible mechanism of action of metronidazole in rosacea and acne","volume":"282","author":"Akamatsu","year":"1990","journal-title":"Arch. Dermatol. Res."},{"key":"2024103109355958100_cit2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-4632.2004.02371.x","article-title":"Correlates of health-related quality of life in women with severe facial blemishes","volume":"45","author":"Balkrishnan","year":"2006","journal-title":"Int. J. Dermatol."},{"key":"2024103109355958100_cit3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/sder.2001.27553","article-title":"Rosacea: current thoughts on origin","volume":"20","author":"Bamford","year":"2001","journal-title":"Semin. Cutan. Med. Surg."},{"key":"2024103109355958100_cit4","doi-asserted-by":"crossref","first-page":"xiii","DOI":"10.1111\/j.0022-202X.2004.22625.x","article-title":"ROS: a step closer to elucidating their role in the etiology of light-induced skin disorders","volume":"122","author":"Black","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"2024103109355958100_cit5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1468-3083.2003.00751.x","article-title":"Antioxidant activity, lipid peroxidation and skin diseases. What's new","volume":"17","author":"Briganti","year":"2003","journal-title":"J. Eur. Acad. Dermatol. Venereol"},{"key":"2024103109355958100_cit6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000082564","article-title":"Rosacea: an update","volume":"210","author":"Buechner","year":"2005","journal-title":"Dermatology"},{"key":"2024103109355958100_cit7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0076-6879(78)52032-6","article-title":"Microsomal lipid peroxidation","volume":"52","author":"Buege","year":"1978","journal-title":"Methods Enzymol."},{"key":"2024103109355958100_cit8","first-page":"21","article-title":"Rosacea subtypes: a treatment algorithm","volume":"74","author":"Dahl","year":"2004","journal-title":"Cutis"},{"key":"2024103109355958100_cit9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14656566.5.1.5","article-title":"Medical treatment of rosacea with emphasis on topical therapies","volume":"5","author":"del Rosso","year":"2004","journal-title":"Expert Opin. Pharmacother."},{"key":"2024103109355958100_cit10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF01646108","article-title":"Impact of topical metronidazole on the skin and colon microflora in patients with rosacea","volume":"15","author":"Eriksson","year":"1987","journal-title":"Infection"},{"key":"2024103109355958100_cit11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic. Biol. Med."},{"key":"2024103109355958100_cit12","first-page":"1","article-title":"Topical metronidazole for rosacea","volume":"7","author":"Gupta","year":"2002","journal-title":"Skin Ther. Lett."},{"key":"2024103109355958100_cit13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1468-3083.2005.01216.x","article-title":"Rosacea and its management: an overview","volume":"19","author":"Gupta","year":"2005","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"2024103109355958100_cit14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jaad.2005.07.057","article-title":"The flushing patient: differential diagnosis, workup, and treatment","volume":"55","author":"Izikson","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"2024103109355958100_cit15","first-page":"17","article-title":"Reactive oxygen species and rosacea","volume":"74","author":"Jones","year":"2004","journal-title":"Cutis"},{"key":"2024103109355958100_cit16","volume-title":"Licht und Haut. Br\u00e4unung, Lichtschutz, Pflege: ein Leitfaden f\u00fcr die Beratung in der Praxis","author":"Kindl","year":"1998"},{"key":"2024103109355958100_cit17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02850193","article-title":"Potential antioxidant mechanism of action for metronidazole: implications for rosacea management","volume":"18","author":"Miyachi","year":"2001","journal-title":"Adv. Ther."},{"key":"2024103109355958100_cit18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2133.1986.tb02802.x","article-title":"Anti-oxidant action of metronidazole: a possible mechanism of action in rosacea","volume":"114","author":"Miyachi","year":"1986","journal-title":"Br. J. Dermatol."},{"key":"2024103109355958100_cit19","first-page":"23","article-title":"Topical therapies for rosacea","volume":"5","author":"Nally","year":"2006","journal-title":"J. Drugs Dermatol."},{"key":"2024103109355958100_cit20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2230.2003.01179.x","article-title":"The role of free oxygen radicals in the aetiopathogenesis of rosacea","volume":"28","author":"\u00d6ztas","year":"2003","journal-title":"Clin. Exp. Dermatol."},{"key":"2024103109355958100_cit21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1039\/b502522b","article-title":"Pathophysiology of photo-aging of human skin: focus on neutrophils","volume":"5","author":"Rijken","year":"2006","journal-title":"Photochem. Photobiol. Sci."},{"key":"2024103109355958100_cit22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2004.11.003","article-title":"Protective properties of melatonin-loaded nanoparticles against lipid peroxidation","volume":"289","author":"Schaffazick","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"Suppl. 1","key":"2024103109355958100_cit23","first-page":"49","article-title":"Role of psychological factors in course of the rosacea","volume":"50","author":"Sowinska-Glugiewicz","year":"2005","journal-title":"Rocz. Akad. Med. Bialymst."},{"key":"2024103109355958100_cit24","first-page":"494","article-title":"Screening for new antioxidative compounds for topical administration using skin lipid model systems","volume":"8","author":"Trommer","year":"2005","journal-title":"J. Pharm. Pharmacol. Sci."},{"key":"2024103109355958100_cit25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0939-6411(01)00140-0","article-title":"The examination of skin lipid model systems stressed by ultraviolet irradiation in the presence of transition metal ions","volume":"51","author":"Trommer","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"2024103109355958100_cit26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0378-5173(03)00033-4","article-title":"The effects of hyaluronan and its fragments on lipid models exposed to UV irradiation","volume":"254","author":"Trommer","year":"2003","journal-title":"Int. J. Pharm."},{"key":"2024103109355958100_cit27","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1211\/002235703322461569","article-title":"Examinations of the antioxidative properties of the topically administered drug bufexamac reveal new insights into its mechanism of action","volume":"55","author":"Trommer","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"key":"2024103109355958100_cit28","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/15230860260220175","article-title":"Oxidative stress and its role in skin disease","volume":"4","author":"Trouba","year":"2002","journal-title":"Antioxid. Redox Signal."},{"key":"2024103109355958100_cit29","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jaad.2004.01.048","article-title":"Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea","volume":"50","author":"Wilkin","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"2024103109355958100_cit30","first-page":"1","article-title":"An update on the role of topical metronidazole in rosacea","volume":"11","author":"Zip","year":"2006","journal-title":"Skin Ther. Lett."}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1211%2Fjpp.59.8.0010","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/59\/8\/1125\/60255973\/jpp.59.8.0010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/59\/8\/1125\/60255973\/jpp.59.8.0010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T09:47:00Z","timestamp":1730368020000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/59\/8\/1125\/6141734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,1]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2007,8,1]]},"published-print":{"date-parts":[[2007,8,1]]}},"URL":"https:\/\/doi.org\/10.1211\/jpp.59.8.0010","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,8]]},"published":{"date-parts":[[2007,8,1]]}}}